114 related articles for article (PubMed ID: 7197965)
21. Influence of hepatic and renal disorders on the pharmacokinetics of sulfachloropyridacine.
Mariño EL; Dominguez-Gil A; Tabernero JM; Macias JG
Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):10-4. PubMed ID: 7364528
[TBL] [Abstract][Full Text] [Related]
22. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
[TBL] [Abstract][Full Text] [Related]
23. Multiple-dose kinetics and dialyzability of oxazepam in renal insufficiency.
Greenblatt DJ; Murray TG; Audet PR; Locniskar A; Koepke HH; Walker BR
Nephron; 1983; 34(4):234-8. PubMed ID: 6877459
[No Abstract] [Full Text] [Related]
24. Influence of renal dysfunction on warfarin plasma protein binding.
Bachmann K; Shapiro R; Mackiewicz J
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):468-72. PubMed ID: 977790
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of flecainide.
Conard GJ; Ober RE
Am J Cardiol; 1984 Feb; 53(5):41B-51B. PubMed ID: 6364769
[TBL] [Abstract][Full Text] [Related]
26. Bioavailability and pharmacokinetics of oxazepam.
Sonne J; Loft S; Døssing M; Vollmer-Larsen A; Olesen KL; Victor M; Andreasen F; Andreasen PB
Eur J Clin Pharmacol; 1988; 35(4):385-9. PubMed ID: 3197746
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetic studies on absorption and excretion of oxazepam in Combination with alcohol (author's transl)].
Mallach HJ; Moosmayer A; Gottwald K; Staak M
Arzneimittelforschung; 1975 Nov; 25(11):1840-5. PubMed ID: 1106447
[TBL] [Abstract][Full Text] [Related]
28. Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam.
Patel M; Tang BK; Grant DM; Kalow W
Pharmacogenetics; 1995 Oct; 5(5):287-97. PubMed ID: 8563769
[TBL] [Abstract][Full Text] [Related]
29. [The influence of chronic renal insufficiency on the demethylating activities of various cytochrome P-450 subspecies in humans].
Simon HU; Günther K; Balogh A; Ortweiler W; Splinter FK; Stein G; Traeger A
Pharmazie; 1985 Nov; 40(11):790-2. PubMed ID: 4095132
[TBL] [Abstract][Full Text] [Related]
30. Oxazepam pharmacokinetics in patients with epilepsy treated long-term with phenytoin alone or in combination with phenobarbitone.
Scott AK; Khir AS; Steele WH; Hawksworth GM; Petrie JC
Br J Clin Pharmacol; 1983 Oct; 16(4):441-4. PubMed ID: 6626439
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacokinetics of ketoprofen in patients with renal failure].
Stafanger G; Larsen HW; Hansen H; Serensen K
Sem Hop; 1983 Dec; 59(46):3191-3. PubMed ID: 6318338
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacokinetic studies of 5-nitrox in kidney failure patients].
Mikhaĭlova D; Viktorov I; Dzhoneĭdi M; Mikhaĭlova S; Tsenova Z
Eksp Med Morfol; 1981; 20(3):160-6. PubMed ID: 7030715
[TBL] [Abstract][Full Text] [Related]
33. Disposition of oxazepam in patients on maintenance hemodialysis.
Ochs HR; Greenblatt DJ; Klehr U
Klin Wochenschr; 1984 Aug; 62(16):765-7. PubMed ID: 6482312
[TBL] [Abstract][Full Text] [Related]
34. Renal disease, age, and oxazepam kinetics.
Murray TG; Chiang ST; Koepke HH; Walker BR
Clin Pharmacol Ther; 1981 Dec; 30(6):805-9. PubMed ID: 7307429
[TBL] [Abstract][Full Text] [Related]
35. Oxidative versus conjugative biotransformation of temazepam.
Locniskar A; Greenblatt DJ
Biopharm Drug Dispos; 1990; 11(6):499-506. PubMed ID: 2207300
[TBL] [Abstract][Full Text] [Related]
36. Clinical pharmacokinetics of oxazepam and lorazepam.
Greenblatt DJ
Clin Pharmacokinet; 1981; 6(2):89-105. PubMed ID: 6111408
[TBL] [Abstract][Full Text] [Related]
37. Effect of pentobarbital on the formation of diastereomeric oxazepam glucuronides in man: analysis by high performance liquid chromatography.
Seideman P; Ericsson O; Gröningsson K; von Bahr C
Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):200-4. PubMed ID: 7336978
[TBL] [Abstract][Full Text] [Related]
38. Oxazepam pharmacokinetics in thyroid disease.
Scott AK; Khir AS; Bewsher PD; Hawksworth GM
Br J Clin Pharmacol; 1984 Jan; 17(1):49-53. PubMed ID: 6419761
[TBL] [Abstract][Full Text] [Related]
39. [Practical aspects of pharmacokinetics in renal failure].
Orzechowska-Juzwenko K; Janicki AG
Pol Tyg Lek; 1982 Oct; 37(39):1181-4. PubMed ID: 7163064
[No Abstract] [Full Text] [Related]
40. The pharmacokinetic profile of oxazepam.
Alván G; Odar-Cederlöf I
Acta Psychiatr Scand Suppl; 1978; (274):47-55. PubMed ID: 282777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
